64 related articles for article (PubMed ID: 12685315)
21. Differential immunogenicity of HIV-1 clade C proteins in eliciting CD8+ and CD4+ cell responses.
Ramduth D; Chetty P; Mngquandaniso NC; Nene N; Harlow JD; Honeyborne I; Ntumba N; Gappoo S; Henry C; Jeena P; Addo MM; Altfeld M; Brander C; Day C; Coovadia H; Kiepiela P; Goulder P; Walker B
J Infect Dis; 2005 Nov; 192(9):1588-96. PubMed ID: 16206073
[TBL] [Abstract][Full Text] [Related]
22. Human cytomegalovirus (CMV)-specific CD8+ T cell responses are reduced in HIV-infected individuals with a history of CMV disease despite CD4+ T cell recovery.
Singh KP; Howard JL; Wild SP; Jones SL; Hoy J; Lewin SR
Clin Immunol; 2007 Aug; 124(2):200-6. PubMed ID: 17574925
[TBL] [Abstract][Full Text] [Related]
23. [The rapid and slow progression of HIV infection].
Soriano V; Martín R; del Romero J
Rev Clin Esp; 1995 Oct; 195(10):708-14. PubMed ID: 8532928
[No Abstract] [Full Text] [Related]
24. Acute hepatitis C in HIV-infected patients: rare spontaneous clearance correlates with weak memory CD4 T-cell responses to hepatitis C virus.
Schnuriger A; Dominguez S; Guiguet M; Harfouch S; Samri A; Ouazene Z; Slama L; Simon A; Valantin MA; Thibault V; Autran B;
AIDS; 2009 Oct; 23(16):2079-89. PubMed ID: 19710595
[TBL] [Abstract][Full Text] [Related]
25. Impact of antiretroviral therapy and changes in virus load on human immunodeficiency virus (HIV)-specific T cell responses in primary HIV infection.
Lacabaratz-Porret C; Urrutia A; Doisne JM; Goujard C; Deveau C; Dalod M; Meyer L; Rouzioux C; Delfraissy JF; Venet A; Sinet M
J Infect Dis; 2003 Mar; 187(5):748-57. PubMed ID: 12599048
[TBL] [Abstract][Full Text] [Related]
26. Simultaneous activation of viral antigen-specific memory CD4+ and CD8+ T-cells using mRNA-electroporated CD40-activated autologous B-cells.
Van den Bosch GA; Van Gulck E; Ponsaerts P; Nijs G; Lenjou M; Apers L; Kint I; Heyndrickx L; Vanham G; Van Bockstaele DR; Berneman ZN; Van Tendeloo VF
J Immunother; 2006; 29(5):512-23. PubMed ID: 16971807
[TBL] [Abstract][Full Text] [Related]
27. Predictive value of immune parameters before treatment interruption (TI) for CD4+ T-cell count change during TI in HIV infection.
Huang KH; Loutfy MR; Boulet S; Toma E; Tsoukas CM; Bernard NF
Antivir Ther; 2009; 14(3):381-92. PubMed ID: 19474472
[TBL] [Abstract][Full Text] [Related]
28. Memory CD8+ T cells in HIV infection.
McMichael AJ; Ogg G; Wilson J; Callan M; Hambleton S; Appay V; Kelleher T; Rowland-Jones S
Philos Trans R Soc Lond B Biol Sci; 2000 Mar; 355(1395):363-7. PubMed ID: 10794056
[TBL] [Abstract][Full Text] [Related]
29. Immunization with an HIV-1 immunogen induces CD4+ and CD8+ HIV-1-specific polyfunctional responses in patients with chronic HIV-1 infection receiving antiretroviral therapy.
Valor L; Navarro J; Carbone J; Rodríguez-Sáinz C; Gil J; López F; Fernández-Cruz E;
Vaccine; 2008 May; 26(22):2738-45. PubMed ID: 18433946
[TBL] [Abstract][Full Text] [Related]
30. CD8 T-cell response to antiretroviral therapy.
Stricker RB; Goldberg B
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jun; 15(2):176-7. PubMed ID: 9241121
[No Abstract] [Full Text] [Related]
31. Reply to Thysen et al.
Tchakoute CT; Hesseling AC; Blakney AK; Jaspan HB
J Infect Dis; 2015 Oct; 212(8):1342-3. PubMed ID: 25821228
[No Abstract] [Full Text] [Related]
32. Changes in BCG Vaccination Policy Should Consider the Effect on Child Health.
Thysen SM; Aaby P; Benn CS; Fisker AB
J Infect Dis; 2015 Oct; 212(8):1341-2. PubMed ID: 25821229
[No Abstract] [Full Text] [Related]
33. First evidence of HIV infection of CD8 lymphocytes expressing CD4 during primary HIV-1 infection.
Cochrane A; Hughes GJ; Seaton RA; Simmonds P
AIDS; 2005 Jul; 19(11):1237-9. PubMed ID: 15990582
[No Abstract] [Full Text] [Related]
34. Delayed BCG vaccination--time to take a shot.
Kay AW; Blish CA
J Infect Dis; 2015 Feb; 211(3):335-7. PubMed ID: 25108029
[No Abstract] [Full Text] [Related]
35. T-cell repertoire and HIV infection: facts and perspectives.
Cossarizza A
AIDS; 1997 Jul; 11(9):1075-88. PubMed ID: 9233453
[No Abstract] [Full Text] [Related]
36. Current understanding in HIV immunopathology and treatment.
Williams JP; Frater J
QJM; 2012 Aug; 105(8):725-8. PubMed ID: 22294649
[No Abstract] [Full Text] [Related]
37. Blocking of HIV entry through CD44-hyaluronic acid interactions.
Turville S
Immunol Cell Biol; 2014 Oct; 92(9):735-6. PubMed ID: 25155464
[No Abstract] [Full Text] [Related]
38. How to "spot" a real killer.
Snyder JE; Mosmann TR
Trends Immunol; 2003 May; 24(5):231; author reply 231-2. PubMed ID: 12738412
[No Abstract] [Full Text] [Related]
39. HIV infection and immune system in genesis of coronary lesions.
de Lorgeril M; Boissonnat P; Dureau G; Renaud S
Lancet; 1992 Nov; 340(8829):1226-7. PubMed ID: 1359295
[No Abstract] [Full Text] [Related]
40. Immunoendocrinological hypothesis of HIV infection.
Rook GA; Onyebujoh P; Stanford JL
Lancet; 1994 Sep; 344(8923):681. PubMed ID: 7915362
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
